March 29, 2022
Rejuvenate Biomed Started a Groundbreaking Clinical Trial and Expands for Future Growth
Rejuvenate Biomed NV (“Rejuvenate”), a biomedical company developing novel combination drugs for age-related diseases, has provided an update on its development pipeline and strategy.